Shanghai Baolijia Chemical Co. Ltd. (301037) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Shanghai Baolijia Chemical Co. Ltd. stock ¥6.66, price ¥10.53, that is 36.8% below the price, quality 42 out of 100. Rating: strongly overvalued. Calculated from audited financials with 7 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range ¥6.36 – ¥20.07 · fair‑value band ¥5.76 – ¥8.14 · the ¥10.53 price screens above the ¥6.66 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Shanghai Baolijia Chemical Co. in your weekly email
Every Wednesday you see whether Shanghai Baolijia Chemical Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Shanghai Baolijia Chemical Co., Ltd. researches, develops, produces, and sells water-based acrylic emulsions in the People's Republic of China and internationally.
Show moreShow less
The company offers architectural emulsions, waterproof emulsions, textile emulsions, textile additives, packaging emulsions, additives, and other functional products, as well as construction field and industrial paint emulsions.
Shanghai Baolijia Chemical Co., Ltd. was founded in 2001 and is headquartered in Shanghai, the People's Republic of China.
Stock analysis
Shanghai Baolijia Chemical Co. Ltd. (301037) currently trades at ¥10.53, while our model-based Fair Value estimate is ¥6.66, 37% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of ¥3.35 per share, and 0 of the 7 models we run sit above the ¥10.53 price.
Bear case: the Asset-Based group reads lowest at ¥2.31, and 7 of the 7 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ¥5.76 (bear) to ¥8.14 (bull), the price of ¥10.53 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 42/100 (below-average quality), in the Basic Materials sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Shanghai Baolijia Chemical Co. Ltd. reported revenue of 1.7B CNY in FY2025 versus 3.0B CNY in FY2021, a compound −13.2%/yr. Reported net income was −55.4M CNY in FY2025.
Key figures
Market cap 1.5B CNY (≈ $219M) Micro · P/S ratio 0.95 · EPS (TTM) ¥−0.6700 · Dividend yield 2.0% · Net margin −5.8% · Return on equity −15.9% · Return on assets (EBIT) 0.7% (5-year average) · Operating margin 0.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).
What moves the price
The share trades about 40% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −41% fair-value upside, at −37%, 301037 screens cheaper than that median.
Fair Value models
Bear¥5.76Fair Value ¥6.66Bull¥8.14
Price ¥10.53 · Downside -36.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF¥2.88¥3.33¥4.0782
Growth DCF¥2.93¥3.35¥3.9980
5Y EBITDA Exit¥3.72¥5.03¥6.7776
All 7 models by family
DCF Models
FCF DCF¥2.88¥3.33¥4.0782
5Y Revenue Exit¥2.00¥2.07¥2.1574
5Y EBITDA Exit¥3.72¥5.03¥6.7776
10Y Revenue Exit¥2.41¥2.49¥2.5568
10Y EBITDA Exit¥3.31¥4.08¥4.8970
Asset-Based
NCAV (Graham)¥1.72¥2.31¥3.4554
Growth DCF
Growth DCF¥2.93¥3.35¥3.9980
The fair value above starts from this blend and is adjusted for a cyclical trough year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.18/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−21.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−18.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.5%
Start year 2020 (pandemic)
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.2%
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
7.2% (2020) → −0.4% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Shanghai Baolijia Chemical Co. Ltd. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 728 stocks
Beats the industry median on 3/11 measures
Overall it trails its industry peers.
Valuation
Quality Score42 · Bottom 25%
Fair Value upside−36.8% · Below median
Profitability
Return on assets−2.4% · Bottom 25%
Net margin (12 months)−5.8% · Bottom 25%
Operating margin (12 months)0.0% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)−1.6% · Bottom 25%
Dividend yield (12 months)2.0% · Above median
Balance sheet
Debt / equity0.02× · Below median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/B2.56× · Pricier than median
P/S (12 months)0.91× · Cheaper than median
EV/EBITDA38.6× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)0· sector 67
PAST (return on equity)0· sector 27
HEALTH (low debt)99· sector 95
DIVIDEND (yield)39· sector 30
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Shanghai Baolijia Chemical Co. Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/301037
Frequently asked questions
Is Shanghai Baolijia Chemical Co. Ltd. (301037) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of ¥6.66 versus a price of ¥10.53, about 37% lower (overvalued).
What is the fair value of 301037?
Our model-based fair value for Shanghai Baolijia Chemical Co. Ltd. is ¥6.66 (as of Nov 6, 2026), built from audited fundamentals. The current price: ¥10.53.
What is the quality score of 301037?
Shanghai Baolijia Chemical Co. Ltd. has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Shanghai Baolijia Chemical Co. Ltd. (301037)?
Our model-based price target is the fair value of ¥6.66 (as of Nov 6, 2026) from 7 valuation models. Cautious scenario ¥5.76, optimistic scenario ¥8.14. It is a calculation from audited fundamentals, not an analyst target.
What is the Shanghai Baolijia Chemical Co. Ltd. stock forecast for 2026?
Our models put fair value at ¥6.66, about 37% lower versus a price of ¥10.53 (overvalued). Cautious scenario ¥5.76, optimistic scenario ¥8.14. The calculation is refreshed regularly with new filings.
What is the revenue of Shanghai Baolijia Chemical Co. Ltd. (301037)?
Shanghai Baolijia Chemical Co. Ltd. reported trailing-twelve-month revenue of about 1.6B CNY (latest available figure, as of Nov 6, 2026).
Does Shanghai Baolijia Chemical Co. Ltd. pay a dividend?
Shanghai Baolijia Chemical Co. Ltd. currently shows a dividend yield of 1.95% relative to its recent price (as of Nov 6, 2026).
How much is the dividend of Shanghai Baolijia Chemical Co. Ltd. (301037)?
Shanghai Baolijia Chemical Co. Ltd. has a dividend yield of 2.0%.
What is the intrinsic value of Shanghai Baolijia Chemical Co. Ltd. (301037)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Shanghai Baolijia Chemical Co. Ltd. it is ¥6.66 per share (as of Nov 6, 2026), against a price of ¥10.53. It is the blended result of 7 valuation models in 3 families (DCF Models, Asset-Based, Growth DCF).
Is Shanghai Baolijia Chemical Co. Ltd. stock overvalued or undervalued in 2026?
As of Nov 6, 2026, 301037 trades above its calculated fair value: price ¥10.53, fair value ¥6.66, a gap of about −37% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 301037?
No. The price is what the market pays today (¥10.53); the fair value is what the company's own numbers justify (¥6.66). For Shanghai Baolijia Chemical Co. Ltd. the two are ¥3.87 per share apart. That gap is exactly why we show both numbers side by side.
How much is Shanghai Baolijia Chemical Co. Ltd. worth?
The market values Shanghai Baolijia Chemical Co. Ltd. at about 1.5B CNY (market capitalisation, as of Nov 6, 2026). Per share that is ¥10.53; our models calculate a fair value of ¥6.66 per share.
What do the bullish and bearish scenarios say about 301037?
Our models span a range for Shanghai Baolijia Chemical Co. Ltd.: cautious scenario ¥5.76, base ¥6.66, optimistic ¥8.14 per share (as of Nov 6, 2026, price ¥10.53). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Shanghai Baolijia Chemical Co. Ltd. (301037)?
Balance-sheet figures for Shanghai Baolijia Chemical Co. Ltd. (as of Nov 6, 2026): return on equity −15.9%, debt of 0.02 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is 301037 from its 52-week high?
Shanghai Baolijia Chemical Co. Ltd. trades at ¥10.53, about 40% below its 52-week high of ¥17.48 and 3% above the low of ¥10.22 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of ¥6.66 is for.
Which stocks are comparable to Shanghai Baolijia Chemical Co. Ltd.?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Shanghai Baolijia Chemical Co. Ltd. stock attractive at the current price?
The data as of Nov 6, 2026: price ¥10.53, calculated fair value ¥6.66 (−37%), Quality Score 42/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 301037 calculated?
We run Shanghai Baolijia Chemical Co. Ltd. through 7 models from 3 families: DCF Models, Asset-Based, Growth DCF. Every model gets the same audited fundamentals; the fair value of ¥6.66 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Shanghai Baolijia Chemical Co. Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Shanghai Baolijia Chemical Co. Ltd. (301037)?
The closing price on Nov 9, 2026 was ¥10.53. Our model-based fair value is ¥6.66, about 37% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Shanghai Baolijia Chemical Co. Ltd. right now?
The price sits above even our optimistic bull case (¥8.14). The favourable scenario is already priced in. Weak quality (42/100) and above fair value at the same time, the margin of safety is missing on both counts.
Key figures of Shanghai Baolijia Chemical Co. Ltd.
How large is the market capitalisation of Shanghai Baolijia Chemical Co. Ltd. (301037)?
The market capitalisation of Shanghai Baolijia Chemical Co. Ltd. is 1.5B CNY (≈ $219M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Shanghai Baolijia Chemical Co. Ltd. (301037)?
The price-to-sales ratio of Shanghai Baolijia Chemical Co. Ltd. is 0.95 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Shanghai Baolijia Chemical Co. Ltd. (301037)?
Earnings per share at Shanghai Baolijia Chemical Co. Ltd. are ¥−0.6700. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Shanghai Baolijia Chemical Co. Ltd. (301037)?
The dividend yield of Shanghai Baolijia Chemical Co. Ltd. is 2.0%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Shanghai Baolijia Chemical Co. Ltd. (301037)?
The net margin of Shanghai Baolijia Chemical Co. Ltd. is −5.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Shanghai Baolijia Chemical Co. Ltd. (301037)?
The return on equity (ROE) of Shanghai Baolijia Chemical Co. Ltd. is −15.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Shanghai Baolijia Chemical Co. Ltd. (301037)?
On an EBIT basis the return on assets of Shanghai Baolijia Chemical Co. Ltd. is 0.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Shanghai Baolijia Chemical Co. Ltd. (301037)?
The operating margin of Shanghai Baolijia Chemical Co. Ltd. is 0.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Shanghai Baolijia Chemical Co. Ltd. (301037)?
Revenue at Shanghai Baolijia Chemical Co. Ltd. is growing −1.6% versus a year earlier (3y avg −18.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Shanghai Baolijia Chemical Co. Ltd. (301037)?
Earnings per share at Shanghai Baolijia Chemical Co. Ltd. are growing +427% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Shanghai Baolijia Chemical Co. Ltd. (301037) generate?
The free cash flow of Shanghai Baolijia Chemical Co. Ltd. is 534K CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Shanghai Baolijia Chemical Co. Ltd. (301037) carry?
The net debt of Shanghai Baolijia Chemical Co. Ltd. is 929M CNY (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Shanghai Baolijia Chemical Co. Ltd. in the live analysis
One click puts Shanghai Baolijia Chemical Co. Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 6, 2026